Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic efficacy of oral BTA798 in an experimental human rhinovirus challenge model
2008-001714-24Phase 2Terminated
- Sponsor
- Biota Holdings Limited
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rhinoviral infection and nasopharyngitis comparing BTA798 prophylaxis with Placebo (2 arms). Primary endpoints: Prevention of HRV infection and Reduction in severity of HRV infection. Started May 2008; status: terminated.
02
Drugs
Vapendavir
03
Conditions
rhinoviral infectionnasopharyngitis
Beyond the preview
Go deeper on 2008-001714-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001714-24.